EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

A murine model of amyloid‐enhanced tauopathy: Comparison of wild‐type and P301L‐tau

Dylan J Finneran iD, Taylor Desjarlais, Brianna M Jackman, Marcia N Gordon iD, David Morgan

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71788 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.10.2026. Verfasst von Dylan J Finneran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health (NIH), NIA NIH HHS, Coins for Alzheimer's Research Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION To optimize a model of amyloid‐enhanced tauopathy we compared wild‐type (WT) tau with P301L‐tau in a mouse with mature amyloid. METHODS Mice transgenic for amyloid precursor protein and presenilin‐1 (APP+PS1, A/P) were injected intravenously with adeno‐associated virus with capsid B10 (AAV.CAP‐B10) expressing either WT or P301L human tau. Mice were behaviorally assessed 5 and 8 months and tissue collected 9 months after injection. RESULTS A/P+WT and A/P+P301L groups were equivalently impaired in spatial learning and memory. A/P+WT mice had significantly greater tau hyperphosphorylation than A/P+P301L mice. However, A/P+P301L mice had greater deposition of phospho‐tau and formation of Gallyas‐positive neurofibrillary tangles (NFTs). DISCUSSION These data demonstrate that WT‐tau is more highly phosphorylated than P301L‐tau in the presence of amyloid in mouse brain. Furthermore, despite the lack of NFT pathology in A/P+WT mice, WT‐tau still caused cognitive impairment. The use of WT‐tau in this model may make it more translatable for pre‐clinical assessments of potential therapeutics for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTauopathiesBrainAnimalsMice, TransgenicDisease Models, AnimalHumansPresenilin-1MiceNeurofibrillary TanglesPhosphorylationAmyloid beta-Protein PrecursorMaze LearningDependovirus

Stichwörter der Autor:innen

Alzheimer's diseaseGallyas silver stainadeno‐associated viruscognitive impairmentneurofibrillary tanglesphosphorylated tauwild‐type tau

Substanzen

tau ProteinsPresenilin-1Amyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.

ORCID-Profile: Dylan J Finneran, Marcia N Gordon

Förderung

  • National Institutes of Health (NIH)
  • NIA NIH HHS
  • Coins for Alzheimer's Research Trust
  • Alzheimer's Association
  • National Institute on Aging

Zitieren

APA

Finneran, D. J., Desjarlais, T., Jackman, B. M., Gordon, M. N., & Morgan, D. (2026). A murine model of amyloid‐enhanced tauopathy: Comparison of wild‐type and P301L‐tau. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71788

Vancouver

Finneran DJ, Desjarlais T, Jackman BM, Gordon MN, Morgan D. A murine model of amyloid‐enhanced tauopathy: Comparison of wild‐type and P301L‐tau. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71788

BibTeX
@article{Finneran2026,
  author = {Finneran, Dylan J and Desjarlais, Taylor and Jackman, Brianna M and Gordon, Marcia N and Morgan, David},
  title = {A murine model of amyloid‐enhanced tauopathy: Comparison of wild‐type and P301L‐tau},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71788}
}
Kostenlos starten →